Tate Michael Truett 的 Form 4/A 修正申報
修正Astera Labs, Inc.（ALAB），2025/8/20 申報
- 申報編號
- 0001736297-25-000108
- 申報時間
- 2025/8/20
- 交易日
- 2025/8/7-8/8
- 申報延遲
- 13 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2025/8/11
這份申報列了 6 筆非衍生性交易。沿用原件裡沒有重述的 1 筆交易。公開市場賣出合計 $1,714 萬。交易後 13 天申報。
這份修正申報重述了 0001736297-25-000102（2025/8/11 申報）的一部分，沒有重述的交易仍然有效，列在下面。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Tate Michael TruettCIK 0001399546 | 高階主管（財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/8/7 | Common Stock | S賣出處分 | −43,184 | $169.61F1 | −$7,324,438.24 | 575,812 | 間接 | |
| 2025/8/7 | Common Stock | S賣出處分 | −7,550 | $170.34F3 | −$1,286,067 | 568,262 | 間接 | |
| 2025/8/7 | Common Stock | S賣出處分 | −15,141 | $171.48F4 | −$2,596,378.68 | 553,121 | 間接 | |
| 2025/8/7 | Common Stock | S賣出處分 | −34,125 | $173.82F5 | −$5,931,607.5 | 518,996 | 間接 | |
| 2025/8/7 | Common Stock | G贈與處分 | −7,500 | $0.00 | $0 | 511,496 | 間接 | |
| 2025/8/8 | Common Stock | G贈與處分 | −10,000 | $0.00 | $0 | 501,496 | 間接 |
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效，網站的交易表把它們算在這份修正申報底下。
來自 0001736297-25-000102（2025/8/11 申報）。
非衍生性證券（表 I）
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/8/7 | Common Stock | G贈與取得 | +7,500 | $0.00 | $0 | 7,500 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F2
These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents a bona fide gift of shares to a non-affiliated entity.
- F7
Represents a bona fide gift of shares to a non-affiliated person.
備註
This Form 4/A (this "Amendment") amends and restates in its entirety the original Form 4 filed with the U.S. Securities and Exchange Commission on August 11, 2025 (the "Original Form") to remove the transaction relating to the acquisition of Astera Labs, Inc. common stock ("Common Stock") by GlobalStar Donor Advised Fund ("DAF"), of which the Reporting Person was inadvertently reported due to administrative error as being a trustee. In fact, the Reporting Person has no pecuniary interest in GlobalStar DAF; as such, the 7,500 shares were gifted to and acquired by a non-affiliated entity, as reported in this Amendment.